BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Inflammatory disorder
,
Embryo
,
Biofuel
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD96;jsessionid=740AF2B6FE1DA3A9F657A139FBA0E957
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thymus gland
Ileum mucosa
Spleen
Lymph nodes
Tonsil
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Hitting the complexity of the TIGIT-CD96-CD112R-CD226 axis for next-generation cancer immunotherapy.
CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma.
BCL9 regulates CD226 and CD96 checkpoints in CD8+ T cells to improve PD-1 response in cancer.
CD96 as a Potential Diagnostic Biomarker and New Target for Skin Cutaneous Melanoma.
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for CD96;jsessionid=740AF2B6FE1DA3A9F657A139FBA0E957
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ